THE OPEN-LABEL MULTICENTRAL STUDY OF ANTIHYPERTENSIVE FIXED-DOSE COMBINATION EFFECTIVENESS IN UKRAINE.

Journal of hypertension(2022)

引用 0|浏览1
暂无评分
摘要
Only 62.5% of hypertensive patients are on FDC therapy in Ukraine. More frequently use of FDC was associated with improving patient compliance. The 2- or 3-component Olmesartan based FDCs were more effective in BP decreasing than routine antihypertensive therapy.
更多
查看译文
关键词
open-label,fixed-dose
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要